• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

ATL results dip due to HDI 5000 intro

Article

HDI 5000 may represent the future for ATL Ultrasound, but expenses associated with the rollout of the new super-premium ultrasound scanner had a negative impact on the Bothell, WA, company's financial results for the third quarter (end-September). Still,

HDI 5000 may represent the future for ATL Ultrasound, but expenses associated with the rollout of the new super-premium ultrasound scanner had a negative impact on the Bothell, WA, company's financial results for the third quarter (end-September). Still, ATL executives say HDI 5000 is off to a roaring start, with deliveries scheduled for this quarter.

ATL had revenues of $93 million for the third quarter, down 7% compared with sales of $100.3 million in the third quarter of 1996. The firm's net loss for the most recent period was $2 million, compared with net income of $3.8 million in the same quarter a year ago.

ATL attributed the lower revenues to delays in customer order placement that followed HDI 5000's introduction in July, while expenses rose as the company readied the product for market (SCAN 8/6/97). Revenues and gross margin were also affected by the higher dollar, which negatively impacted the company's international business.

In other ATL news, the company announced last week that it has released a radiology version of its Tissue Harmonic Imaging technique, which previously had been available only for cardiology applications. The technique is available on the company's HDI 3000 scanner and will be offered on HDI 5000 when it begins shipping.

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.